AI takes the wheel: smart insulin pump tested in toddlers

NCT ID NCT06017089

Completed Disease control Sponsor: Marc Breton Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This pilot study tested an artificial intelligence system that helps manage insulin delivery in young children (ages 2 to 6) with type 1 diabetes. The system combines a continuous glucose monitor, an insulin pump, and an AI advisor that adjusts pump settings automatically. Thirty-three children used the system at home for eight weeks to see if it was safe and improved blood sugar control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-based Advisor system (Tandem t:slim X2 with Control-IQ, Dexcom CGM, and cloud dashboard)
What this could lead to: If successful, this AI system could help young children with type 1 diabetes maintain safer blood sugar levels with less effort from parents.
What could go wrong: This is a small pilot study with only 33 children, so results may not apply to everyone. The AI system may not work as well in real-world conditions or for all age groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Barbara Davis Center, University of Colorado

Aurora, Colorado, 80045, United States
Stanford University

Stanford, California, 94305, United States
University of Virginia

Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.